Month: November 2016

No more false dawns: how fusion biopsies and new diagnostic pathways are ending the uncertainty of ‘false negatives’

The most significant developments in my field recently have not been in how we treat prostate cancer, but what we do beforehand, to assess and understand the disease. Six years ago, like all UK urologists, the prostate biopsy I commonly used was the TRUS (transrectal ultrasound-guided biopsy). It involves inserting 12 needles through the rectum […]

Read more